360Dx Cancer Bulletin: Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ

Cancer Bulletin In-Depth Reporting From The 360Dx Newsroom

Planning Your 2019 Marketing Strategy? 360Dx can help! Contact our advertising sales team to learn about our diverse range of online marketing offerings. Whatever your business goals or budget, 360Dx will work closely with you to ensure your success. Contact adsales@360Dx.com for our 2019 media kit. Recent Premium Articles   Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ Published on Jan 15, 2019   Seer Biosciences Leveraging $36M, Proteomic Nanotech for Early Detection Test Development Published on Jan 10, 2019 Recent Free Articles   Roche, PhoenixMD Collaborating on CDx for Triple-Negative Breast Cancer Drug Published on Jan 16, 2019   Cigna Covering Vermillion's OVA1 Ovarian Cancer Test Published on Jan 15, 2019   CellMax Life Highlights Liquid Biopsy Platform's Ability to Detect Pre-Cancer, Cancer Published on Jan 14, 2019   Foundation Medicine Says Tumor Mutational Burden Reporting Issue on CDx Test Is Resolved Published on Jan 11, 2019   JP Morgan Healthcare, Day 4: OraSure, Meridian Bioscience, Biocartis, Veracyte Published on Jan 11, 2019   Pillar Biosciences, China Biotech Services Form Joint Venture Published on Jan 10, 2019   New Natera CEO Highlights Three Goals for Company at JP Morgan Published on Jan 10, 2019 Evaluating the Agilent HCM Mastr Assay with Seraseq Cardiomyopathy Reference Material This white paper from SeraCare shows how the Seraseq Cardiomyopathy Reference Material is capable of rapid evaluation of the HCM MASTR assay, allowing for easy and rapid implementation of the assay. Download it from GenomeWeb's White Paper Channel. Recommended for You free   GenMark Fungal Blood Culture Test Clears FDA Published on Dec 26, 2018 free   NX Prenatal Collaborating With Milu Labs to Launch Preterm Birth Test in Asia Published on Jan 16, 2019 Development of Reference Materials for NGS based Somatic Variant Detection and Fusion Detection in Myeloid Cancers  This Scientific Poster from SeraCare provides reference materials that may aid the development, optimization, and verification of NGS-based myeloid disease testing. Download it from GenomeWeb’s White Paper Channel. Job listings Scientific Director Company: National Library of Medicine Location: Bethesda MD Apply now Assay Development Scientist Company: Incredible Life Science Company in Holland, Michigan Location: Holland MI Apply now Computational Immunology Scientist Company: DxTerity Location: Rancho Dominguez CA Apply now Staff Scientist & Lab Manager, Knowles Lab Company: New York Genome Center Location: New York NY Apply now NGS-based Somatic Variant and Fusion Detection in Myeloid Cancers This Scientific Poster Video from SeraCare demonstrates how reference materials can aid in the development, optimization, and verification of NGS-based myeloid disease tests. Download it from GenomeWeb’s library